British Patient Capital
United Kingdombritishpatientcapital.co.uk
Overview
British Patient Capital is the UK's largest domestic investor in venture and venture growth opportunities . With more than £3bn of assets under management, its mission is to enable long-term investment in innovative UK companies led by ambitious entrepreneurs who want to build successful, world-class businesses . By focusing on the late-stage funding gap, it helps ensure high-growth UK companies have access to the right type of funding at the right time in their life-cycle, supporting them as they expand, create jobs, develop products and enter new markets .
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Nuclera Nucleics | Jan 2026 | Series C | Co-investor |
| Paragraf | Aug 2025 | Series C | Co-investor |
| Maxion Therapeutics | Mar 2025 | Series A | Co-investor |
| Quantexa | Mar 2025 | Series F | - |
| Cambridge GaN Devices | Feb 2025 | Series C | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.